These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15126656)

  • 21. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
    Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
    J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.
    Lafuente S; Fuster D; Arguis P; Granados U; Perlaza P; Paredes P; Vollmer I; Sánchez M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):226-31. PubMed ID: 26848142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience.
    de Baere T; Robinson JM; Rao P; Teriitehau C; Deschamps F
    J Vasc Interv Radiol; 2011 Jun; 22(6):749-54. PubMed ID: 21616429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
    Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
    J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
    VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
    AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
    Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
    J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.
    Suzawa N; Yamakado K; Takao M; Taguchi O; Yamada T; Takeda K
    Clin Nucl Med; 2013 Apr; 38(4):e166-70. PubMed ID: 23429399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma.
    Kodama H; Yamakado K; Hasegawa T; Takao M; Taguchi O; Fukai I; Sakuma H
    J Vasc Interv Radiol; 2014 Mar; 25(3):333-9. PubMed ID: 24581457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
    Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA
    AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous radiofrequency ablation for lung tumors beneath the rib under CT fluoroscopic guidance with gantry tilt.
    Suzuki T; Yamagami T; Tanaka O; Yoshimatsu R; Miura H; Nishimura T
    Acta Radiol; 2010 May; 51(4):389-95. PubMed ID: 20380601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors.
    Higuchi M; Suzuki H; Gotoh M
    PET Clin; 2016 Jan; 11(1):47-55. PubMed ID: 26590443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
    de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
    Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
    Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
    J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
    Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
    Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation of lung malignancies: where do we stand?
    Lencioni R; Crocetti L; Cioni R; Mussi A; Fontanini G; Ambrogi M; Franchini C; Cioni D; Fanucchi O; Gemignani R; Baldassarri R; Angeletti CA; Bartolozzi C
    Cardiovasc Intervent Radiol; 2004; 27(6):581-90. PubMed ID: 15578133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
    Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT-guided radiofrequency ablation for lung cancer.
    Matsuoka T; Okuma T
    Int J Clin Oncol; 2007 Apr; 12(2):71-8. PubMed ID: 17443273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK
    Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
    Hasegawa T; Yamakado K; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Miki M; Sasaki T; Sakuma H; Sugimura Y
    Radiology; 2015 Nov; 277(2):584-93. PubMed ID: 25997031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.